Stoess, Christian
Onyuru, Janset
Hartmann, Phillipp
Hoffman, Hal M.
Broderick, Lori
Feldstein, Ariel E.
Article History
First Online: 17 October 2025
Competing interests
: H.M.H. has consulted for Novartis, SOBI and Ventyx and has research collaborations with Regeneron, Jecure, Inapill and Zomagen. L.B. was a site principal investigator for Novartis, and speaker for SOBI. A.E.F. is an employee and stockholder of Pfizer. The remaining authors declare no competing interests.